Ethics & Informed Consent: Prospective Cohort Study (Portugal)
A detailed academic review of the ethical submission protocol, informed consent prerequisites, and reporting standards for conducting a Prospective Cohort Study within the regulatory framework of Portugal.
1. Ethical Principles & Legislative Framework
In research involving human participants, securing ethical clearance is a critical first step. For a Prospective Cohort Study being conducted in Portugal, study designs must align with the primary regulatory legislation: Clinical Research Act (Law 21/2014). This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.
National Ethics Board Clearance Pathway
In Portugal, clinical studies require review by CEIC and/or institutional CES. Consent documents must specify data ownership and meet INFARMED standards.
Administrative review and formal approval are managed by a local or regional Comissão de Ética para a Investigação Clínica (CEIC). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.
2. Study Design Elements & Reporting Integrity
For a Prospective Cohort Study, the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.
Study Classification: Minimal to Moderate Risk (Observational)
This longitudinal design monitors cohorts prospectively. Informed consent documents must disclose future follow-up intervals and secure medical database linking rules.
To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: STROBE guidelines.
Special Directive: Observational Study Protocols
As an observational or non-interventional design, the ethics board primarily focuses on data privacy, secure pseudonymisation, and informed consent. If you are conducting retrospective database research, you may apply for a waiver of consent, provided participant risk is minimised.
3. Informed Consent & Information Sheet Guidelines
A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:
Design-Specific Consent Focus Areas
Explicit consent for long-term health registry tracking, linkage to electronic health records, and future contact.
- Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
- Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
- Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under EU GDPR & Portuguese Data Protection Act (Law 58/2019).
- Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
- Ethics Board Contact Information: Provide the contact details of the reviewing Comissão de Ética para a Investigação Clínica (CEIC) so participants can reach out if they have questions or concerns.
Research Ethics, Clinical Trials & Institutional Governance
The data capture guidelines match the Declaration of Helsinki ethical principles to protect individual identifiers from disclosure. The protocol must outline safe pathways, particularly if any minor deception in psychological research is used in questionnaires. The consenting procedure must follow the ethical principles of informed consent, ensuring participants can opt out anytime. While observational work rarely requires a clinical trial registration, a signed clinical trial agreement contract is required for health networks. Submitting a verified data sharing agreement is necessary to secure final research ethics approval from the Comissão de Ética para a Investigação Clínica (CEIC). Ethical oversight committees in Portugal audit the study's consent registry periodically to verify compliance with national legal statutes.
4. Regulatory Checklist Table
To streamline your ethical review submission, use the structured alignment checklist below:
| Requirement | Comissão de Ética para a Investigação Clínica (CEIC) Standard | STROBE guidelines Standard |
|---|---|---|
| Consent Form | Signed and dated prior to study activity. Focus: Explicit consent for long-term health registry tracking. | Fully documented recruitment and consent paths. |
| Risk Management | Comprehensive risk mitigation plan. Enforcing multi-factor database security and maintaining a secure key for participant pseudonymisation. | Adverse events reporting strategy. |
| Data Retention | Compliance with local data protection rules (EU GDPR & Portuguese Data Protection Act (Law 58/2019)). | Provision of open-data options where possible. |
5. Academic & Research Infrastructure Matrix (Portugal)
The following authenticated registry lists top scientific organizations, clinical laboratories, and research hospitals in Portugal mapped via the Research Organization Registry (ROR) standards-compliance framework.
| Organization Name | Sector Type | Registry Identification |
|---|---|---|
| Altice Portugal (Portugal) | company | ROR IDWikidata/Wiki |
| Teva Portugal | company | ROR ID |
| Livraria Portugal (Portugal) | company | ROR ID |
| Alfasigma Portugal (Portugal) | company | ROR ID |
| Affidea Portugal | company | ROR ID |
| Logiters Portugal | company | ROR ID |
| WSA Portugal (Portugal) | company | ROR ID |
| Vygon Portugal | company | ROR ID |
| Upstream Portugal | company | ROR ID |
| MPO Portugal (Portugal) | company | ROR ID |
| SHL Portugal | company | ROR ID |
| SGS Portugal (Portugal) | company | ROR ID |
| Deloitte Portugal (Portugal) | company | ROR ID |
| Águas de Portugal (Portugal) | company | ROR IDWikidata/Wiki |
| Infraestruturas de Portugal (Portugal) | company | ROR ID |
6. Frequently Asked Questions
How long does the review process normally take?
Review timelines depend on the volume of applications and whether your proposal qualifies for expedited review. On average, a standard review by an ethics board in Portugal takes between 4 to 8 weeks.
Can we use digital signatures for informed consent?
Yes, digital consent forms are increasingly accepted, provided the platform used is secure, authenticates the identity of the signer, and complies with local regulations such as the eIDAS or ESIGN Act, depending on country-specific rules.
Regulatory Context
Verified Funding Bodies
Funder registries and DOI configurations verified for compliance in Portugal via Crossref.
- Comité Olímpico de PortugalID: 501100023847 | Location: Portugal
- Carnegie Mellon PortugalID: 100019678 | Location: Portugal
- Bayer PortugalID: 501100019189 | Location: Portugal
- Fulbright PortugalID: 501100014070 | Location: Portugal
- MIT PortugalID: 501100019186 | Location: Portugal
- Banco de PortugalID: 501100019247 | Location: Portugal
- Fundação Portugal TelecomID: 501100008683 | Location: Portugal
- Novartis PortugalID: 100020604 | Location: Portugal
- Fundação GrünenthalID: 501100010289 | Location: Portugal
- OSRAMID: 100031434 | Location: Portugal
Pre-Submission Warning
Do not recruit participants or initiate study procedures before receiving official written approval from your reviewing board. Ethical approvals cannot be granted retrospectively under Clinical Research Act (Law 21/2014).
